logo

For the Inventor, By the Inventor

Oradell, NJ, United States of America

Martin J Weiss

This inventor holds 85 USPTO granted patents and 6 published patent applications, primarily in Prostaglandin Chemistry (CPC class 560121). Top assignees: American Cyanamid Company, American Cyanamid, Other. Active years: 1976-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin J Weiss. Retrieved from https://idiyas.com/inventor/martin-j-weiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 85 

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 11

Forward Citations = 1,661(Granted Patents)

Forward Citations (Not Self Cited) = 1,636(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Oredell, NJ (US) (1978)
  • Bergen, NJ (US) (1980)
  • Oradell, NJ (US) (1976 - 1985)
  • Fort Lee, NJ (US) (1988 - 1989)
  • Ft. Lee, NJ (US) (1998 - 1999)

Company Filing History:

goldMedal82 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal1 out of 33 
 
American Cyanamid
 patents
bronzeMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-1999

Loading Chart...
Areas of Expertise:
Prostaglandins
Antitumor Agents
Conjugates
Methyltrithio
Hydroxy Substituted
Epoxycyclopentanones
B-Lymphocyte Suppression
Tetranorprostanoic Acids
Prostenoic Acids
Ethynyl Substituted
Linkers
Synthesis
85 patents (USPTO):Explore Patents
1. 5877296 - Process for preparing conjugates of methyltrithio antitumor agents (1999-03-02),
2. 5773001 - Conjugates of methyltrithio antitumor agents and intermediates for their (1998-06-30),
3. 5767285 - Linkers useful for the synthesis of conjugates of methyltrithio (1998-06-16),
4. 5739116 - Enediyne derivatives useful for the synthesis of conjugates of (1998-04-14),
5. 4861579 - Suppression of B-lymphocytes in mammals by administration of (1989-08-29),
6. 4730065 - 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1988-03-08),
7. 4535180 - 11-Deoxy-11-substituted prostaglandins of the E and F series (1985-08-13),
8. 4518790 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1985-05-21),
9. 4504417 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1985-03-12),
10. 4444691 - 11-Cyano-prostaglandins of the F-series (1984-04-24),
11. 4439365 - Novel hydroxy substituted prostanoic acids, esters, congeners, (1984-03-27),
12. 4429148 - 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners (1984-01-31),
13. 4415746 - 16-Aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives (1983-11-15),
14. T103403 - 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic (1983-09-05),
15. 4387241 - Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives (1983-06-07),

Title: Martin J Weiss: Innovator in Antitumor Agents

Introduction

Martin J Weiss, based in Oradell, NJ, is a prolific inventor with an impressive track record of 85 patents. His innovative contributions primarily focus on the development of conjugates that leverage disulfide analogs of powerful antitumor antibiotics, showcasing his commitment to advancing cancer treatment.

Latest Patents

Among his latest patents are remarkable inventions related to the preparation of conjugates of methyltrithio antitumor agents. This invention outlines a process for creating carrier-drug conjugates derived from the calicheamicin family of potent antitumor antibiotics, alongside derivatives and related analogs from other antitumor antibiotics like esperamicins. The innovations involve the use of carriers, including antibodies, growth factors, or steroids, designed to target undesirable cell populations such as tumor cells. Furthermore, his patents encompass the necessary compounds for synthesizing these conjugates, appropriate pharmaceutical compositions, and comprehensive methods for their application.

Career Highlights

Throughout his career, Martin has made significant strides in the field of biotechnology. He has worked with esteemed organizations, including the American Cyanamid Company, where he contributed to various research initiatives and the advancement of pharmaceutical science.

Collaborations

In his professional journey, Martin collaborated with notable individuals such as Robert E Schaub and Charles V Grudzinskas, further enhancing the scope and impact of his work in the pharmaceutical industry.

Conclusion

Martin J Weiss stands out as a key figure in the fight against cancer through innovative drug delivery systems. His extensive patent portfolio exemplifies his dedication to improving therapeutic options for patients while opening avenues for further research and collaboration in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…